RGEN

Repligen News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Repligen Corp RGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
2.41 1.11% 219.32 20:00:00
Open Price Low Price High Price Close Price Prev Close
216.54 216.142 219.44 219.32 216.91
more quote information »

Recent News

Date Time Source Heading
1/06/202116:42EDGARStatement of Changes in Beneficial Ownership (4)
1/04/202113:00GLOBERepligen Corporation to Present at 39th Annual J.P. Morgan..
12/10/202016:17GLOBERepligen Corporation Announces Closing of Public Offering of..
12/08/202016:05EDGARCurrent Report Filing (8-k)
12/08/202012:20PRNUSEC Mergers & Acquisitions advised ARTeSYN on its Sale to..
12/07/202021:40GLOBERepligen Corporation Prices Public Offering of Shares of..
12/07/202007:24EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/07/202007:21GLOBERepligen Corporation Announces Proposed Public Offering of..
11/13/202016:47EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202016:53EDGARQuarterly Report (10-q)
11/05/202007:52EDGARCurrent Report Filing (8-k)
11/05/202007:30GLOBERepligen Reports Third Quarter 2020 Financial Results and..
10/27/202016:18EDGARCurrent Report Filing (8-k)
10/27/202016:15GLOBERepligen Corporation Announces Agreement to Acquire..
10/22/202007:30GLOBERepligen to Report Third Quarter 2020 Financial Results
10/01/202006:30GLOBERepligen and Navigo Proteins Announce Achievement of Key..
9/14/202007:44EDGARStatement of Changes in Beneficial Ownership (4)
8/10/202017:36EDGARStatement of Changes in Beneficial Ownership (4)
7/30/202018:44EDGARQuarterly Report (10-q)
7/30/202007:51EDGARCurrent Report Filing (8-k)
7/30/202007:30GLOBERepligen Reports Second Quarter 2020 Financial Results and..
7/15/202007:30GLOBERepligen to Report Second Quarter 2020 Financial Results
7/10/202017:05EDGARCurrent Report Filing (8-k)
6/29/202016:02EDGARCurrent Report Filing (8-k)
6/29/202007:30GLOBERepligen Announces Agreement to Acquire Engineered Molding..
6/22/202016:43EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202019:11EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202019:08EDGARInitial Statement of Beneficial Ownership (3)
6/15/202007:30GLOBERepligen Appoints Carrie Eglinton Manner to Board of..
5/15/202017:43EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202017:39EDGARStatement of Changes in Beneficial Ownership (4)
5/15/202016:30EDGARCurrent Report Filing (8-k)
5/06/202016:13EDGARQuarterly Report (10-q)
5/06/202007:52EDGARCurrent Report Filing (8-k)
5/06/202007:30GLOBERepligen Reports First Quarter 2020 Financial Results and..
4/28/202017:00EDGARProxy Statement (definitive) (def 14a)
4/24/202017:23EDGARStatement of Changes in Beneficial Ownership (4)
4/22/202018:08EDGARStatement of Changes in Beneficial Ownership (4)
4/22/202007:30GLOBERepligen to Report First Quarter 2020 Financial Results
4/06/202019:35EDGARStatement of Changes in Beneficial Ownership (4)
3/26/202019:32EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202016:26EDGARStatement of Changes in Beneficial Ownership (4)
3/18/202017:10EDGARStatement of Changes in Beneficial Ownership (4)
3/05/202017:54EDGARStatement of Changes in Beneficial Ownership (4)
3/05/202017:54EDGARStatement of Changes in Beneficial Ownership (4)
3/05/202017:54EDGARStatement of Changes in Beneficial Ownership (4)
3/05/202017:52EDGARStatement of Changes in Beneficial Ownership (4)
3/05/202017:51EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202018:00EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202017:57EDGARInitial Statement of Beneficial Ownership (3)
See more news about this stock »


Your Recent History
NASDAQ
RGEN
Repligen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.